# Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

> **NCT01930461** · PHASE2 · COMPLETED · sponsor: **Stallergenes Greer** · enrollment: 386 (actual)

## Conditions studied

- Asthma
- House Dust Mite Allergy

## Interventions

- **BIOLOGICAL:** SLIT tablets of HDM allergen extracts, 3 different doses (A)
- **BIOLOGICAL:** SLIT tablets of HDM allergen extracts, 3 different doses (B)
- **BIOLOGICAL:** SLIT tablets of HDM allergen extracts, 3 different doses (C)
- **BIOLOGICAL:** Placebo matching the SLIT tablets of HDM allergen extracts

## Key facts

- **NCT ID:** NCT01930461
- **Lead sponsor:** Stallergenes Greer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 386 (ACTUAL)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01930461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01930461, "Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01930461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*